Abiraterone Acetate and Castration Resistant Ductal Adenocarcinoma of the Prostate

@inproceedings{LindenCastro2014AbirateroneAA,
  title={Abiraterone Acetate and Castration Resistant Ductal Adenocarcinoma of the Prostate},
  author={Edgar Linden-Castro and Marcela Pelayo-Nieto and Alejandro Al{\'i}as-Melgar and Daniel Espinosa-Perezgrovas and Iv{\'a}n Ram{\'i}rez-Galindo and Gabriel Catal{\'a}n-Quinto},
  booktitle={Case reports in urology},
  year={2014}
}
Ductal adenocarcinoma of the prostate is a rare histological variant that only represents <1% of prostate tumors. This histological variant has several important clinical implications with respect to their evolution, clinical prognosis, and treatment. We report the case of a 64-year-old patient with ductal adenocarcinoma of the prostate, which progresses to… CONTINUE READING